Cryo-VaccTM
Cryo-Vacc is a revolutionary solution developed by Renergen Limited that maintains precise temperatures for vaccines and biologics, especially in remote and under-resourced areas. It uses innovative engineering, liquid nitrogen, helium, and telematics to ensure safe transportation, storage, and tracking of vaccines without reliance on external power sources. The company aims to improve cold chain management, reduce vaccine wastage, and increase trust through transparency and advanced monitoring systems. Cryo-Vacc's solutions are designed to address global challenges in vaccine distribution, particularly in Africa and Southeast Asia, by providing durable, portable, and efficient cold storage units that operate effectively in harsh conditions.
Industries
Nr. of Employees
small (1-50)
Cryo-VaccTM
Sandton Gate, 25 Minerva Ave, Glenadrienne, Sandton, 2196, Second Floor (C/O Renergen)
Products
Cryogenic transport unit – Mini
Small transportable cryogenic container variant with ~5 L internal volume, designed for short-range or low-volume vaccine distribution.
Cryogenic transport unit – Medium
Medium-capacity cryogenic container variant for larger vaccine loads and longer-range distribution.
Cryogenic transport unit – Jumbo
Large-capacity cryogenic container variant intended for high-volume distribution and mass-vaccination logistics.
Cryogenic transport unit – Mini
Small transportable cryogenic container variant with ~5 L internal volume, designed for short-range or low-volume vaccine distribution.
Cryogenic transport unit – Medium
Medium-capacity cryogenic container variant for larger vaccine loads and longer-range distribution.
Cryogenic transport unit – Jumbo
Large-capacity cryogenic container variant intended for high-volume distribution and mass-vaccination logistics.
Services
Provision of transportable cryogenic storage units on monthly or fixed-term rental agreements that include regular servicing, calibration, unit replacement and technical support to maintain validated temperatures.
Cloud-accessible telemetry service that logs temperature trends and GPS location during distribution; provides public-accessible verification of cold-chain integrity via a mobile interface.
Provision of transportable cryogenic storage units on monthly or fixed-term rental agreements that include regular servicing, calibration, unit replacement and technical support to maintain validated temperatures.
Cloud-accessible telemetry service that logs temperature trends and GPS location during distribution; provides public-accessible verification of cold-chain integrity via a mobile interface.
Expertise Areas
- Cold-chain logistics for biologics
- Cryogenic systems engineering
- Vaccine distribution and storage
- Remote telemetry and IoT temperature monitoring
Key Technologies
- Liquid helium cryogenic cooling
- Liquid nitrogen cryogenic cooling (alternative)
- Passive cryogen reservoir systems
- GPS location tracking
News & Updates
South Africa’s Renergen has patented cryogenic cases that can keep vaccines at ultra-cold temperatures for 30 days, enabling transport to remote areas without power.
Renergen has developed a device that keeps Covid-19 vaccines ultra-cold for up to 30 days, simplifying logistics and enabling access to remote regions.
Renergen has designed a lightweight aluminium device to transport Covid vaccines at ultra-low temperatures, leveraging helium and natural gas resources.
A device that allows vaccines to be transported at -70°C to -150°C for more than four weeks without power.
Renergen has patented cryogenic cases for vaccines that can operate at ultra-cold temperatures for 30 days, suitable for remote areas.
A South African company has developed a helium-based container that can keep vaccines at -70°C for up to 30 days without power, aiding logistics in remote areas.
South Africa’s Renergen has patented cryogenic cases that can keep vaccines at ultra-cold temperatures for 30 days, enabling transport to remote areas without power.
Renergen has developed a device that keeps Covid-19 vaccines ultra-cold for up to 30 days, simplifying logistics and enabling access to remote regions.
Renergen has designed a lightweight aluminium device to transport Covid vaccines at ultra-low temperatures, leveraging helium and natural gas resources.
A device that allows vaccines to be transported at -70°C to -150°C for more than four weeks without power.
Renergen has patented cryogenic cases for vaccines that can operate at ultra-cold temperatures for 30 days, suitable for remote areas.
A South African company has developed a helium-based container that can keep vaccines at -70°C for up to 30 days without power, aiding logistics in remote areas.